Condition: Breast Neoplasms · Sponsor: Spanish Breast Cancer Research Group
This study is a prospective, multicenter non-interventional cohort study designed to develop a registry in unresectable locally advanced or metastatic disease.
This description comes directly from the study's public registry record.
MS Study Project Manager · +34 916892870 · inicio_ensayos@geicam.org
Start-Up Unit Manager · +34 916892870 · inicio_ensayos@geicam.org
Always discuss trial participation with your own doctor first.
| Hospital General de Elche | Elche, Alicante, Spain | Recruiting |
| Althaia-Xarxa Assistencial de Manresa | Manresa, Barcelona, Spain | Recruiting |
| Consorci Sanitari de Terrassa | Terrassa, Barcelona, Spain | Recruiting |
| Hospital Universitario Donostia | San Sebastián, Donostia, Spain | Recruiting |
| Hospital Dr. Negrín | Las Palmas de Gran Canaria, Gran Canaria, Spain | Recruiting |
| Hospital Universitario Fundación Alcorcón | Alcorcón, Madrid, Spain | Recruiting |
| Hospital Universitario de Fuenlabrada | Fuenlabrada, Madrid, Spain | Recruiting |
| Hospital Universitario Severo Ochoa | Leganés, Madrid, Spain | Recruiting |
| Hospital Infanta Sofía | San Sebastián de los Reyes, Madrid, Spain | Recruiting |
| Hospital Son Llatzer | Palma de Mallorca, Mallorca, Spain | Recruiting |
| Complejo Hospitalario de Navarra | Pamplona, Navarre, Spain | Recruiting |
| Hospital Universitario de Canarias | Santa Cruz de Tenerife, Tenerife, Spain | Recruiting |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02819882